Koyfin Home > Directory > Health Care > Antares Pharma > Cash from Financing Activities

Antares Pharma Cash from Financing Activities Chart (ATRS)

Antares Pharma annual/quarterly Cash from Financing Activities from 2000 to 2018.
  • Antares Pharma Cash from Financing Activities for the quarter ending September 09, 2018 was $0m a 143.57% decrease of 0m year over year
  • Antares Pharma Cash from Financing Activities for the last 12 months ending September 09, 2018 was $0m a 82,203.13% decrease of -26m year over year
  • Antares Pharma Annual Cash from Financing Activities for 2017 was $26m a 99.94% increase of 26m from 2016
  • Antares Pharma Annual Cash from Financing Activities for 2016 was $0m a -251,629.41% decrease of -43m from 2015
  • Antares Pharma Annual Cash from Financing Activities for 2015 was $43m a 93.10% increase of 40m from 2014
Other Cash Flow Metrics:
  • Antares Pharma Cash Flow from Operations for the quarter ending September 09, 2018 was $0m a -9,658.63% increase of 8m year over year
  • Antares Pharma Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $0m a -10,730.73% increase of 6m year over year
  • Antares Pharma Total Revenue for the quarter ending December 12, 2018 was $19m a 32.51% increase of 6m year over year
View Chart On Koyfin

Quarterly ATRS Cash from Financing Activities Data

09/2018$0m
06/2018$0m
03/2018$0m
12/2017$0m
09/2017$0m
06/2017$26m
03/2017$0m
12/2016$0m
09/2016$0m
06/2016$0m

Annual ATRS Cash from Financing Activities Data

2017$26m
2016$0m
2015$43m
2014$3m
2013$2m
2012$65m
2011$27m
2010$2m
2009$6m
2008$-1m